INTRODUCTION: Non-adherence to anti-hormonal therapy is a major problem in gynecologic oncology. Reasons reported are side effects and lack of support. The aim of our study was an analysis of influence of experiences of patients with endocrine therapy and communication and information on this topic and their influence on adherence. METHODS: We developed a structured questionnaire which was tested in a pilot version and then programmed as online questionnaire and presented to patient members of self-help and breast cancer organizations. RESULTS: Patients only had received scarce information on endocrine therapy. Only 12.8% stated that their questions were answered in detail, 43.2% got no answers or only non-detailed answers. 76% had side effects limiting functions of daily life. 60% of physicians did not react on these side effects. There is a significant correlation between number and intensity of side effects and non-adherence or disruption of therapy (p = 0.029 and p < 0.01, respectively). Women who reported having received detailed answers to their questions also reported better adherence (p = 0.014). CONCLUSION: In order to improve adherence, detailed information on side effects and answers in case of symptoms are most important. Physicians should not rely on presenting written information but should mainly engage in direct communication.
INTRODUCTION: Non-adherence to anti-hormonal therapy is a major problem in gynecologic oncology. Reasons reported are side effects and lack of support. The aim of our study was an analysis of influence of experiences of patients with endocrine therapy and communication and information on this topic and their influence on adherence. METHODS: We developed a structured questionnaire which was tested in a pilot version and then programmed as online questionnaire and presented to patient members of self-help and breast cancer organizations. RESULTS:Patients only had received scarce information on endocrine therapy. Only 12.8% stated that their questions were answered in detail, 43.2% got no answers or only non-detailed answers. 76% had side effects limiting functions of daily life. 60% of physicians did not react on these side effects. There is a significant correlation between number and intensity of side effects and non-adherence or disruption of therapy (p = 0.029 and p < 0.01, respectively). Women who reported having received detailed answers to their questions also reported better adherence (p = 0.014). CONCLUSION: In order to improve adherence, detailed information on side effects and answers in case of symptoms are most important. Physicians should not rely on presenting written information but should mainly engage in direct communication.
Authors: Annette Wigertz; Johan Ahlgren; Marit Holmqvist; Tommy Fornander; Jan Adolfsson; Henrik Lindman; Leif Bergkvist; Mats Lambe Journal: Breast Cancer Res Treat Date: 2012-05 Impact factor: 4.872
Authors: Willemien van de Water; Esther Bastiaannet; Elysée T M Hille; Elma M Meershoek-Klein Kranenbarg; Hein Putter; Caroline M Seynaeve; Robert Paridaens; Anton J M de Craen; Rudi G J Westendorp; Gerrit-Jan Liefers; Cornelis J H van de Velde Journal: Oncologist Date: 2011-12-30
Authors: A Howell; J Cuzick; M Baum; A Buzdar; M Dowsett; J F Forbes; G Hoctin-Boes; J Houghton; G Y Locker; J S Tobias Journal: Lancet Date: 2005 Jan 1-7 Impact factor: 79.321
Authors: Uwe Güth; Mary Elizabeth Myrick; Nerbil Kilic; Serenella Eppenberger-Castori; Seraina Margaretha Schmid Journal: Breast Cancer Res Treat Date: 2012-01 Impact factor: 4.872
Authors: C Cluze; D Rey; L Huiart; M K BenDiane; A D Bouhnik; C Berenger; M P Carrieri; R Giorgi Journal: Ann Oncol Date: 2011-07-25 Impact factor: 32.976
Authors: Timothy L Lash; Matthew P Fox; Jennifer L Westrup; Aliza K Fink; Rebecca A Silliman Journal: Breast Cancer Res Treat Date: 2006-03-16 Impact factor: 4.872
Authors: Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly Journal: Breast Cancer Res Treat Date: 2012-12-23 Impact factor: 4.872
Authors: Gretchen Kimmick; Sara N Edmond; Hayden B Bosworth; Jeffrey Peppercorn; Paul K Marcom; Kimberly Blackwell; Francis J Keefe; Rebecca A Shelby Journal: Breast Date: 2015-07-16 Impact factor: 4.380
Authors: C C Hack; P Voiß; S Lange; A E Paul; S Conrad; G J Dobos; M W Beckmann; S Kümmel Journal: Geburtshilfe Frauenheilkd Date: 2015-07 Impact factor: 2.915
Authors: Suzanne C O'Neill; Claudine Isaacs; Filipa Lynce; Deena Mary Atieh Graham; Calvin Chao; Vanessa B Sheppard; Yingjun Zhou; Chunfu Liu; Nandini Selvam; Marc D Schwartz; Arnold L Potosky Journal: Breast Cancer Res Date: 2017-03-31 Impact factor: 6.466
Authors: Yura Lee; Yu Rang Park; Ji Sung Lee; Sae Byul Lee; Il Yong Chung; Byung Ho Son; Sei Hyun Ahn; Jong Won Lee Journal: J Breast Cancer Date: 2019-03-11 Impact factor: 3.588
Authors: P Chalela; E Munoz; D Inupakutika; S Kaghyan; D Akopian; V Kaklamani; K Lathrop; A Ramirez Journal: Contemp Clin Trials Commun Date: 2018-10-17